15 June 2026, 10:00
Novel Regulatory Mechanisms of the RAS-ERK Pathway by the Pseudokinase KSR
Description AbstractOur research focuses on the role of RAF kinases in transmitting signals within the RAS RAF MEK ERK RAS ERK cascade Hyperactivation of the RAS ERK pathway caused by activating mutations in RAS and RAF is a major driver of tumor formation in 30 of all cancers1 Improving our understanding on the regulation of the RAS ERK pathway is of paramount importance for the development of next generation therapeutics The RAF family comprises three catalytically active isoforms ARAF BRAF CRAF and two pseudokinase isoforms KSR1 KSR2 which adopts dimers conformation to activate RAF catalytic outputs2 Our goal is to investigate the molecular mechanisms governing the dimerisation of KSRs with RAFs Our investigation uncovered an allosteric mechanism driving KSR1 BRAF heterodimerization and BRAF activation which depends on MEK binding to KSR and on the interactions between the N Terminal domains of KSRs and BRAF3 Additionally we revealed how the scaffold proteins CNK and HYP potentiate this KSR dependent mechanism through the formation of an unexpected CNK HYP MEK KSR quaternary complex4 Employing integrative structural biology techniques combining NMR X Ray crystallography and cryo EM alongside biochemical analyses we aim to deepen our understanding of the pivotal role of the pseudokinase KSR in regulating the RAF kinases providing novel insights into the multi layered regulation of the oncogenic RAS ERK signaling pathway 1Lavoie H et al Nat Rev Mol Cell Biol 2015 10 1038 nrm3979 2Rajakulendran T et al Nature 2009 10 1038 nature083143Lavoie H et al Nature 2018 10 1038 nature254784Maisonneuve P et al Nat Struct Mol Biol 2024 10 1038 s41594 024 01233 6Connection detailsZoom https embl org zoom us j 97170620085 pwd LklFaC4gFmlJHvw5tMSbT2vqaKsaNV 1 Webinar ID 971 7062 0085Passcode 717935Please note that the talk will be recorded For the FAQ section as a zoom participant please use either the chat function the host will read out your question or the raise your hand function and turn on your microphone... AbstractOur research focuses on the role of RAF kinases in transmitting signals within the RAS-RAF-MEK-ERK (RAS/ERK) cascade. Hyperactivation of the RAS/ERK pathway caused by activating mutations in RAS and RAF is a major driver of tumor formation in ~30% of all cancers1. Improving our understanding on the regulation of the RAS/ERK pathway is of paramount importance for the development of next-generation therapeutics. The RAF family comprises three catalytically active isoforms (ARAF, BRAF, CRAF) and two pseudokinase isoforms (KSR1, KSR2), which adopts dimers conformation to activate RAF catalytic outputs2. Our goal is to investigate the molecular mechanisms governing the dimerisation of KSRs with RAFs. Our investigation uncovered an allosteric mechanism driving KSR1:BRAF heterodimerization and BRAF activation, which depends on MEK binding to KSR and on the interactions between the...
Speaker(s): France, CBMN (CNRS UMR5248) – Group leader IECB, Pierre Maisonneuve
Host: Matthew Bowler
Place: EMBL Grenoble Seminar Room
EMBL Grenoble, Virtual
Additional information
Abstract
Our research focuses on the role of RAF kinases in transmitting signals within the RAS-RAF-MEK-ERK (RAS/ERK) cascade. Hyperactivation of the RAS/ERK pathway caused by activating mutations in RAS and RAF is a major driver of tumor formation in ~30% of all cancers1. Improving our understanding on the regulation of the RAS/ERK pathway is of paramount importance for the development of next-generation therapeutics.
The RAF family comprises three catalytically active isoforms (ARAF, BRAF, CRAF) and two pseudokinase isoforms (KSR1, KSR2), which adopts dimers conformation to activate RAF catalytic outputs2. Our goal is to investigate the molecular mechanisms governing the dimerisation of KSRs with RAFs. Our investigation uncovered an allosteric mechanism driving KSR1:BRAF heterodimerization and BRAF activation, which depends on MEK binding to KSR and on the interactions between the N-Terminal domains of KSRs and BRAF3. Additionally, we revealed how the scaffold proteins CNK and HYP potentiate this KSR-dependent mechanism through the formation of an unexpected CNK:HYP:MEK:KSR quaternary complex4.
Employing integrative structural biology techniques combining NMR, X-Ray crystallography and cryo-EM alongside biochemical analyses, we aim to deepen our understanding of the pivotal role of the pseudokinase KSR in regulating the RAF kinases, providing novel insights into the multi-layered regulation of the oncogenic RAS/ERK signaling pathway.
1Lavoie H et.al., Nat Rev Mol Cell Biol (2015) - 10.1038/nrm3979
2Rajakulendran T et.al., Nature (2009) -10.1038/nature08314
3Lavoie H et.al., Nature. (2018) -10.1038/nature25478
4Maisonneuve P et.al., Nat Struct & Mol Biol (2024) -10.1038/s41594-024-01233-6
Connection details
Zoom*: https://embl-org.zoom.us/j/97170620085?pwd=LklFaC4gFmlJHvw5tMSbT2vqaKsaNV.1
Webinar ID: 971 7062 0085
Passcode: 717935
Please note that the talk will be recorded.
*For the FAQ section, as a zoom participant, please use either the chat function (the host will read out your question) or the “raise your hand” function and turn on your microphone.